Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Riv Psichiatr ; 56(2): 57-63, 2021.
Article in English | MEDLINE | ID: covidwho-1202085


Health professionals have been at the frontline of the health service since the outbreak of covid-19, responding promptly to diagnose, support and treat infected patients. World Health Organization (WHO) has already praised their contribution and their essential role in controlling this disease. Some of the main concerns of covid-19's impact to health service staff include work overload, exhaustion, and high risk of self-infection or transmission to family members. Moreover, during the pandemic, caregivers' mental health inevitably becomes vulnerable, with salient stress and anxiety-related symptoms. Uncertainty, fear of contagion, guilt, hopelessness, stigmatization and, in some cases, long-term post-traumatic stress disorder (PTSD) are few of the potential effects posed by this outbreak on health workers. In this review, lessons learnt from previous global crises or pandemics on the psychological impact of health workers are presented. History could potentially provide essential information on how to best manage, support and optimize our approach to this highly appreciated and much needed group of professionals. Targeted and prompt interventions could reduce the psychological strain of health professionals, thus, further improving provided patient care. Covid-19 is an on-going health crisis and this work, even though generated by limited existing data, could be used to inform governments and/or institutions and lead on decisions and changes in current guidelines.

COVID-19 , Health Personnel/psychology , Occupational Diseases/prevention & control , Occupational Diseases/psychology , Psychological Distress , Cost of Illness , Humans , Occupational Diseases/etiology
Int J Cancer ; 148(2): 277-284, 2021 01 15.
Article in English | MEDLINE | ID: covidwho-635339


The age-standardised incidence of cervical cancer in Europe varies widely by country (between 3 and 25/100000 women-years) in 2018. Human papillomavirus (HPV) vaccine coverage is low in countries with the highest incidence and screening performance is heterogeneous among European countries. A broad group of delegates of scientific professional societies and cancer organisations endorse the principles of the WHO call to eliminate cervical cancer as a public health problem, also in Europe. All European nations should, by 2030, reach at least 90% HPV vaccine coverage among girls by the age of 15 years and also boys, if cost-effective; they should introduce organised population-based HPV-based screening and achieve 70% of screening coverage in the target age group, providing also HPV testing on self-samples for nonscreened or underscreened women; and to manage 90% of screen-positive women. To guide member states, a group of scientific professional societies and cancer organisations engage to assist in the rollout of a series of concerted evidence-based actions. European health authorities are requested to mandate a group of experts to develop the third edition of European Guidelines for Quality Assurance of Cervical Cancer prevention based on integrated HPV vaccination and screening and to monitor the progress towards the elimination goal. The occurrence of the COVID-19 pandemic, having interrupted prevention activities temporarily, should not deviate stakeholders from this ambition. In the immediate postepidemic phase, health professionals should focus on high-risk women and adhere to cost-effective policies including self-sampling.

Alphapapillomavirus/immunology , Papillomavirus Infections/immunology , Papillomavirus Vaccines/immunology , Public Health/methods , Uterine Cervical Neoplasms/prevention & control , Adolescent , Adult , Alphapapillomavirus/physiology , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19/virology , Early Detection of Cancer , Europe , Female , Humans , Male , Middle Aged , Pandemics , Papillomavirus Infections/prevention & control , Papillomavirus Infections/virology , Papillomavirus Vaccines/administration & dosage , Public Health/standards , Public Health/statistics & numerical data , SARS-CoV-2/physiology , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/immunology , Vaccination/methods , World Health Organization , Young Adult
Int J Gynecol Cancer ; 30(8): 1097-1100, 2020 08.
Article in English | MEDLINE | ID: covidwho-505825